JAKARTA - Although PT Charlie Hospitals Semarang Tbk (RSCH) revenue increased by 15.04%, the company's losses grew 216.11% in 2024 from 2023. This was due to an increase in cost of revenue and operating expenses.

In the 2024 Financial Report quoted on Friday (28/3), Junianto, President Director of RSCH said that the company's revenue rose to IDR 48.50 billion from IDR 42.15 billion. The largest revenue came from the inpatient segment at IDR 29.34 billion, followed by the outpatient segment at IDR 19.15 billion.

Revenues from the Inpatient segment included Medical Support Services and Experts of IDR19.18 billion, up from IDR15.98 billion, Drugs and Medical Supplies of IDR5.40 billion, up from IDR5.14 billion, Inpatient and Operating Rooms of IDR3.92 billion, up from IDR3.88 billion, Hospital Facilities of IDR346 million, down from IDR391 million, and Administrative and Other Revenues of IDR481 million, down from IDR581 million.

Meanwhile, contributors to the Inpatient segment were Medical Support Services and Experts amounting to IDR12.67 billion, up from IDR10.35 billion, Drugs and Medical Supplies IDR5.12 billion, up from IDR4.25 billion, Hospital Facilities IDR123 million, down from IDR151 million, and Administrative and Other Income IDR1.22 billion, down from IDR1.42 billion.

Gross profit was IDR13.88 billion, up 16.23% from IDR11.94 billion and gross profit margin was 28.62%, up slightly from 28.33%. A 27.43% increase in operating expenses caused gross loss to jump 122% to IDR3.14 billion from IDR1.41 billion. In addition, loss before income tax rose 211.6% to IDR4.08 billion from IDR1.31 billion and loss for the year rose to IDR3.15 billion from IDR1.11 billion. (LK/LM)